Review paper
Two breakthrough gene-targeted treatments for spinal muscular atrophy: challenges remain
Volume: 128, Issue: 8, Pages: 3219 - 3227
Published: Jul 8, 2018
Abstract
The motor neuron disease spinal muscular atrophy (SMA) is caused by recessive, loss-of-function mutations of the survival motor neuron 1 gene (SMN1). Alone, such mutations are embryonically lethal, but SMA patients retain a paralog gene, SMN2, that undergoes alternative pre-mRNA splicing, producing low levels of SMN protein. By mechanisms that are not well understood, reduced expression of the ubiquitously expressed SMN protein causes an...
Paper Details
Title
Two breakthrough gene-targeted treatments for spinal muscular atrophy: challenges remain
Published Date
Jul 8, 2018
Volume
128
Issue
8
Pages
3219 - 3227